Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA (NI-PMS)

Viatris

Status: Completed

Conditions: Neuropathic Pain

Treatments: Drug: Pregabalin

Study type: Observational

Funder types: Industry

Identifiers

NCT00843284

A0081139

ATLAS

Details and patient eligibility

About

A Non-Interventional, Post-Marketing Surveillance (NI-PMS) study whose objectives were to assess the impact of pregabalin on subjects' pain, quality of sleep, and their general wellbeing, as well as the tolerance and safety of pregabalin in subjects with neuropathic pain.

Full description

A non-interventional study of patients diagnosed with neuropathic pain administered pregabalin and followed up for 8 weeks

Enrollment: 691 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of neuropathic pain and inclusion according to the current Summary of Product Characteristics.

Exclusion criteria

• The patients were excluded according to the current Summary of Product Characteristics.

Trial design

691 participants in 1 patient group

Patients with neuropathic pain

Treatment:

Drug: Pregabalin